Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 12/2019

14.09.2019 | Editorial

Cardiac pharmacologic stress: does the gender matters?

verfasst von: Claudio Tinoco Mesquita, Wilter dos Santos Ker

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Excerpt

Men and women have differences and similarities. Some of them are easy to determine and to understand. Some are subtler and more difficult to evaluate. The comprehension of these characteristics is very important to better address health care issues. Cardiovascular disease (CVD) is the leading cause of mortality for women globally, accounting for up to one-third of all deaths in women worldwide [1]. Unfortunately, CVD remains understudied, underdiagnosed, and undertreated in women [2]. There are two main aspects to address in this topic: sex differences resulting from biological factors and gender differences related to social, environmental, and community factors [2]. Women present with angina as the first manifestation of coronary artery disease (CAD) more frequently than men. Women have more diverse symptom presentation than do men: with pain or discomfort in jaw, neck, and interscapular area; associated epigastric discomfort and associated nausea, dyspnea, and fatigue [3]. Acute myocardial infarction (AMI) without chest pain is more common in women and the mortality rate is higher than men [3]. Myocardial ischemia in women is more commonly associated with nonobstructive disease of the epicardial coronary arteries, microvascular disease, and coronary vasospasm. This different pathophysiology is not benign. The WISE Study demonstrated an elevated risk of all-cause mortality among women with signs and symptoms of ischemia but without obstructive coronary artery disease (13%) as compared with women of approximately the same age during the same period (2.8%) [4]. Women are less frequently referred for appropriate treatment during an AMI compared with men despite proven mortality benefits of therapy [2]. Figure 1 provides some of the most important characteristics that the cardiologist and nuclear physician must address in the management of women with suspected or know CAD.
Literatur
1.
Zurück zum Zitat Gholizadeh L, Davidson P. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int. 2008;29(1):3–22.CrossRefPubMed Gholizadeh L, Davidson P. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int. 2008;29(1):3–22.CrossRefPubMed
2.
Zurück zum Zitat Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, Wenger NK; American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133(9):916–47. Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, Wenger NK; American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133(9):916–47.
3.
Zurück zum Zitat Wenger NK. Clinical presentation of CAD and myocardial ischemia in women. J Nucl Cardiol. 2016;23(5):976–85.CrossRefPubMed Wenger NK. Clinical presentation of CAD and myocardial ischemia in women. J Nucl Cardiol. 2016;23(5):976–85.CrossRefPubMed
4.
Zurück zum Zitat Kenkre TS, Malhotra P, Johnson BD, et al. Ten-year mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation). Circ Cardiovasc Qual Outcomes. 2017;10(12):1–9.CrossRef Kenkre TS, Malhotra P, Johnson BD, et al. Ten-year mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation). Circ Cardiovasc Qual Outcomes. 2017;10(12):1–9.CrossRef
5.
Zurück zum Zitat Katsikis A, Kyrozi E, Manira V, Theodorakos A, Malamitsi J, Tsapaki V, Iakovou I, Voudris V, Kolovou G, Koutelou M. Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04463-9. Katsikis A, Kyrozi E, Manira V, Theodorakos A, Malamitsi J, Tsapaki V, Iakovou I, Voudris V, Kolovou G, Koutelou M. Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2019. https://​doi.​org/​10.​1007/​s00259-019-04463-9.
6.
Zurück zum Zitat Thomas GS, Prill NV, Majmundar H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol. 2000;7(5):439–46.CrossRefPubMed Thomas GS, Prill NV, Majmundar H, et al. Treadmill exercise during adenosine infusion is safe, results in fewer adverse reactions, and improves myocardial perfusion image quality. J Nucl Cardiol. 2000;7(5):439–46.CrossRefPubMed
9.
Zurück zum Zitat Reiffel JA. Propensity-score matching: optimal, adequate, or incomplete? J Atr Fibrillation. 2018;11(4):2018–9. Reiffel JA. Propensity-score matching: optimal, adequate, or incomplete? J Atr Fibrillation. 2018;11(4):2018–9.
Metadaten
Titel
Cardiac pharmacologic stress: does the gender matters?
verfasst von
Claudio Tinoco Mesquita
Wilter dos Santos Ker
Publikationsdatum
14.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2019
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04515-0

Weitere Artikel der Ausgabe 12/2019

European Journal of Nuclear Medicine and Molecular Imaging 12/2019 Zur Ausgabe